Vanda shifts into high gear with Schumacher IndyCar sponsorshipFiercepharma·Jul 16 at 01:13 PMVNDA-3.36%
NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment | VNDA Stock NewsStockTitan·Jul 15 at 07:30 AMVNDA-3.36%NTTYY+1.67%
Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit | VNDA Stock NewsStockTitan·Jul 10 at 07:30 AMVNDA-3.36%
FDA grants rare paediatric designation to Vanda’s CMT2S therapyPharmaceutical Technology·Jul 8 at 04:15 AMVNDA-3.36%
Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S | VNDA Stock NewsStockTitan·Jul 7 at 07:30 AMVNDA-3.36%
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarket Beat·May 30 at 01:10 AMVNDA-3.36%VHT+0.58%
Japan's MHLW Grants Orphan Drug Designation To Vanda's Imsidolimab For GP Psoriasisnasdaq·May 28 at 01:45 AMVNDA-3.36%IXJ+0.60%
Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular PsoriasisUnusual Whales·May 27 at 06:03 AMVNDA-3.36%
